Lights and Shadows in Immuno-Oncology Drug Development

gan Bergamino Sirvén, Milana, Pernas, Sonia, Cheang, Maggie C. U.
Cyhoeddwyd yn Cancers (Basel) (2021)

Radiation-Induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

gan Oh, Daniel S., Cheang, Maggie C. U., Fan, Cheng, Perou, Charles M.
Cyhoeddwyd yn Radiat Res (2014)

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

gan Prat, Aleix, Adamo, Barbara, Cheang, Maggie C.U., Anders, Carey K., Carey, Lisa A., Perou, Charles M.
Cyhoeddwyd 2013

A four-gene decision tree signature classification of triple-negative breast cancer: Implications for targeted therapeutics

gan Quist, Jelmar, Mirza, Hasan, Cheang, Maggie C. U., Telli, Melinda L., O'Shaughnessy, Joyce A., Lord, Christopher J., Tutt, Andrew N. J., Grigoriadis, Anita
Cyhoeddwyd yn Mol Cancer Ther (2018)

αB-crystallin expression in breast cancer is associated with brain metastasis

gan Voduc, K David, Nielsen, Torsten O, Perou, Charles M, Harrell, J Chuck, Fan, Cheng, Kennecke, Hagen, Minn, Andy J, Cryns, Vincent L, Cheang, Maggie C U
Cyhoeddwyd yn NPJ Breast Cancer (2015)

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

gan Cheang, Maggie C. U., Chia, Stephen K., Voduc, David, Gao, Dongxia, Leung, Samuel, Snider, Jacqueline, Watson, Mark, Davies, Sherri, Bernard, Philip S., Parker, Joel S., Perou, Charles M., Ellis, Matthew J., Nielsen, Torsten O.
Cyhoeddwyd 2009

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy

gan Prat, Aleix, Fan, Cheng, Fernández, Aranzazu, Hoadley, Katherine A., Martinello, Rossella, Vidal, Maria, Viladot, Margarita, Pineda, Estela, Arance, Ana, Muñoz, Montserrat, Paré, Laia, Cheang, Maggie C. U., Adamo, Barbara, Perou, Charles M.
Cyhoeddwyd yn BMC Med (2015)

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor–positive Breast Cancers

gan Bergamino, Milana A., Morani, Gabriele, Parker, Joel, Schuster, Eugene F., Leal, Mariana F., López-Knowles, Elena, Tovey, Holly, Bliss, Judith M., Robertson, John F.R., Smith, Ian E., Dowsett, Mitch, Cheang, Maggie C.U.
Cyhoeddwyd yn Clin Cancer Res (2022)

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

gan Romero, Atocha, Martín, Miguel, Cheang, Maggie C.U., López García-Asenjo, José Antonio, Oliva, Belén, He, Xiaping, de la Hoya, Miguel, García Sáenz, Jose Ángel, Arroyo Fernández, Manuel, Díaz Rubio, Eduardo, Perou, Charles M., Llopis, Trinidad Caldés
Cyhoeddwyd 2011

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor positive breast cancer

gan Nielsen, Torsten O., Parker, Joel S, Leung, Samuel, Voduc, David, Ebbert, Mark, Vickery, Tammi, Davies, Sherri R., Snider, Jacqueline, Stijleman, Inge J., Reed, Jerry, Cheang, Maggie C.U., Mardis, Elaine R., Perou, Charles M., Bernard, Philip S., Ellis, Matthew J.
Cyhoeddwyd 2010

Predicting drug responsiveness in human cancers using genetically engineered mice

gan Usary, Jerry, Zhao, Wei, Darr, David, Roberts, Patrick J., Liu, Mei, Balletta, Lorraine, Karginova, Olga, Jordan, Jamie, Combest, Austin, Bridges, Arlene, Prat, Aleix, Cheang, Maggie C. U., Herschkowitz, Jason I., Rosen, Jeffrey M., Zamboni, William, Sharpless, Norman E., Perou, Charles M.
Cyhoeddwyd 2013

Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry

gan Milighetti, Martina, Krasny, Lukas, Lee, Alex T.J., Morani, Gabriele, Szecsei, Cornelia, Chen, Yingtong, Guljar, Nafia, McCarthy, Frank, Wilding, Christopher P., Arthur, Amani, Fisher, Cyril, Judson, Ian, Thway, Khin, Cheang, Maggie C.U., Jones, Robin L., Huang, Paul H.
Cyhoeddwyd yn J Proteomics (2021)

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

gan Parker, Joel S., Mullins, Michael, Cheang, Maggie C.U., Leung, Samuel, Voduc, David, Vickery, Tammi, Davies, Sherri, Fauron, Christiane, He, Xiaping, Hu, Zhiyuan, Quackenbush, John F., Stijleman, Inge J., Palazzo, Juan, Marron, J.S., Nobel, Andrew B., Mardis, Elaine, Nielsen, Torsten O., Ellis, Matthew J., Perou, Charles M., Bernard, Philip S.
Cyhoeddwyd 2009

Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial

gan Cheang, Maggie C.U., Voduc, K. David, Tu, Dongsheng, Jiang, Shan, Leung, Samuel, K. Chia, Stephen, Shepherd, Lois E., Levine, Mark N., Pritchard, Kathleen I., Davies, Sherri, Stijleman, Inge J., Davis, Carole, Ebbert, Mark T. W., Parker, Joel S., Ellis, Matthew J., Bernard, Philip S., Perou, Charles M., Nielsen, Torsten O.
Cyhoeddwyd 2012

Genomic complexity profiling reveals that HORMAD1 overexpression contributes to homologous recombination deficiency in triple-negative breast cancers

gan Watkins, Johnathan, Weekes, Daniel, Shah, Vandna, Gazinska, Patrycja, Joshi, Shalaka, Sidhu, Bhavna, Gillett, Cheryl, Pinder, Sarah, Vanoli, Fabio, Jasin, Maria, Mayrhofer, Markus, Isaksson, Anders, Cheang, Maggie C.U., Mirza, Hasan, Frankum, Jessica, Lord, Christopher J., Ashworth, Alan, Vinayak, Shaveta, Ford, James M., Telli, Melinda L., Grigoriadis, Anita, Tutt, Andrew N.J.
Cyhoeddwyd yn Cancer Discov (2015)

Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

gan Cheang, Maggie C.U., Martin, Miguel, Nielsen, Torsten O., Prat, Aleix, Voduc, David, Rodriguez-Lescure, Alvaro, Ruiz, Amparo, Chia, Stephen, Shepherd, Lois, Ruiz-Borrego, Manuel, Calvo, Lourdes, Alba, Emilio, Carrasco, Eva, Caballero, Rosalia, Tu, Dongsheng, Pritchard, Kathleen I., Levine, Mark N., Bramwell, Vivien H., Parker, Joel, Bernard, Philip S., Ellis, Matthew J., Perou, Charles M., Di Leo, Angelo, Carey, Lisa A.
Cyhoeddwyd yn Oncologist (2015)

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial

gan Fontana, Elisa, Nyamundanda, Gift, Cunningham, David, Tu, Dongsheng, Cheang, Maggie C.U., Jonker, Derek J., Siu, Lillian L., Sclafani, Francesco, Eason, Katherine, Ragulan, Chanthirika, Bali, Maria Antonietta, Hulkki-Wilson, Sanna, Loree, Jonathan M., Waring, Paul M., Giordano, Mirella, Lawrence, Patrick, Rodrigues, Daniel Nava, Begum, Ruwaida, Shapiro, Jeremy D., Price, Timothy J., Cremolini, Chiara, Starling, Naureen, Pietrantonio, Filippo, Trusolino, Livio, O’Callaghan, Christopher J., Sadanandam, Anguraj
Cyhoeddwyd yn JCO Precis Oncol (2020)

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

gan Hudeček, Jan, Voorwerk, Leonie, van Seijen, Maartje, Nederlof, Iris, de Maaker, Michiel, van den Berg, Jose, van de Vijver, Koen K., Sikorska, Karolina, Adams, Sylvia, Demaria, Sandra, Viale, Giuseppe, Nielsen, Torsten O., Badve, Sunil S., Michiels, Stefan, Symmans, William Fraser, Sotiriou, Christos, Rimm, David L., Hewitt, Stephen M., Denkert, Carsten, Loibl, Sibylle, Loi, Sherene, Bartlett, John M. S., Pruneri, Giancarlo, Dillon, Deborah A., Cheang, Maggie C. U., Tutt, Andrew, Hall, Jacqueline A., Kos, Zuzana, Salgado, Roberto, Kok, Marleen, Horlings, Hugo M.
Cyhoeddwyd yn NPJ Breast Cancer (2020)

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

gan Esserman, Laura J., Berry, Donald A., Cheang, Maggie C. U., Yau, Christina, Perou, Charles M., Carey, Lisa, DeMichele, Angela, Gray, Joe W., Conway-Dorsey, Kathleen, Lenburg, Marc E., Buxton, Meredith B., Davis, Sarah E., van’t Veer, Laura J., Hudis, Clifford, Chin, Koei, Wolf, Denise, Krontiras, Helen, Montgomery, Leslie, Tripathy, Debu, Lehman, Constance, Liu, Minetta C., Olopade, Olufunmilayo I., Rugo, Hope S., Carpenter, John T., Livasy, Chad, Dressler, Lynn, Chhieng, David, Singh, Baljit, Mies, Carolyn, Rabban, Joseph, Chen, Yunni-Yi, Giri, Dilip, Au, Alfred, Hylton, Nola
Cyhoeddwyd 2011

3D functional genomics screens identify CREBBP as a targetable driver in aggressive triple-negative breast cancer

gan Peck, Barrie, Bland, Philip, Mavrommati, Ioanna, Muirhead, Gareth, Cottom, Hannah, Wai, Patty T., Maguire, Sarah L., Barker, Holly E., Morrison, Eamonn, Kriplani, Divya, Yu, Lu, Gibson, Amy, Falgari, Giulia, Brennan, Keith, Farnie, Gillian, Buus, Richard, Marlow, Rebecca, Novo, Daniela, Knight, Eleanor, Guppy, Naomi, Kolarevic, Daniela, Susnjar, Snezana, Milijic, Natasa Medic, Naidoo, Kalnisha, Gazinska, Patrycja, Roxanis, Ioannis, Pancholi, Sunil, Martin, Lesley-Ann, Holgersen, Erle M, Cheang, Maggie C.U., Noor, Farzana, Postel-Vinay, Sophie, Quinn, Gerard, McDade, Simon, Krasny, Lukas, Huang, Paul, Daley, Frances, Wallberg, Fredrik, Choudhary, Jyoti S., Haider, Syed, Tutt, Andrew N., Natrajan, Rachael
Cyhoeddwyd yn Cancer Res (2021)